26 minutes agoSwiss company willing to donate malaria drug doses to treat Coronobrus
Periskopi(6 years ago)
(6 years ago)The Swiss company Novatitis has expressed willingness to donate enough doses of the malaria drug hydroxchilorine to help treat patients in the fight against Coronobrius, Periscopi broadcast. That if it gets approval, the Swiss company said on Friday, Reuters wrote. There are still no vaccines or treatments approved for the disease, but there is actually a [...]
That if it gets approval, the Swiss company said on Friday, Reuters wrote.
There are still no vaccines or treatments approved for the disease, but there is currently a belief of 1,500 people, led by the University of Minnesota, to see if hydrochlorin can prevent or reduce the severity of COVID-19.
Novattis is a company that produces malaria medicine, which is also used for treatment of lupus and rheumatoid arthritis in their Sandoz unit in the United States. The company plans to donate 130 million doses of medicine and is in talks with US food and medicine administration regulators to enhance its use of the coronary.
In Washington, US President Donald Trump said during a press conference that he is optimistic about using malaria medicine against COVID-19. / P ERISCOPI/
